NASDAQ:PLYX | News | Polaryx Therapeutics, Inc.

PLYX News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-07-21Current reportSEC filingPolaryx Therapeutics, Inc. filed Form 8-KPolaryx Therapeutics, Inc. filed Form 8-K covering items 5.02.
2026-07-17Current reportSEC filingPolaryx Therapeutics, Inc. filed Form 8-KPolaryx Therapeutics, Inc. filed Form 8-K covering items 5.08,8.01.
2026-05-28Current reportSEC filingPolaryx Therapeutics, Inc. filed Form 8-KPolaryx Therapeutics, Inc. filed Form 8-K covering items 1.01,3.02,7.01,9.01.